Filing Flows

Filing Flows › SeaStar Medical Holding (ICU) › Q1 2026 › vs Q4 2025

SeaStar Medical Holding (ICU) Q1 2026 vs Q4 2025 (quarter over quarter)

SeaStar Medical Holding's revenue rose $75K (+18%) from $420K in Q4 2025 to $495K in Q1 2026.

SeaStar Medical Holding, Q1 2026: revenue $495K (+69% year over year), operating margin -727.9%, net loss $3.5M, operating cash flow −$2.8M. The chart draws each line against Q4 2025, the increases inside each band.

SeaStar Medical Holding: what changed, Q1 2026 vs Q4 2025SeaStar Medical Holding: what changed, Q1 2026 vs Q4 2025Working capital & other$1.9MCash used in operations−$1.3MCosts & expenses$665KOperating costs$662KNet loss$617KOperating cash sources$617KNet loss absorbed$617KGeneral & admin$484KResearch & development$144KCost of revenue$34K

Every line

LineQ1 2026Q4 2025Change%
Revenue$495K$420K$75K+18%
Other income, net$85K$112K−$27K-24%
Net loss$3.5M$2.9M$617K+21%
Costs & expenses$4.1M$3.4M$665K+19%
Operating costs$4.1M$3.4M$662K+19%
Income tax$3K$0$3K—
Cost of revenue$46K$12K$34K+283%
Research & development$2.3M$2.2M$144K+7%
General & admin$1.7M$1.2M$484K+40%
Operating cash sources$3.5M$2.9M$617K+21%
Share-based compensation$91K$70K$21K+30%
Working capital & other$669K−$1.3M$1.9M—
Cash used in operations$2.8M$4.1M−$1.3M-33%
Net loss absorbed$3.5M$2.9M$617K+21%

Questions

How much did SeaStar Medical Holding's revenue grow quarter over quarter in Q1 2026?

SeaStar Medical Holding's revenue rose $75K (+18%) from $420K in Q4 2025 to $495K in Q1 2026.

Q1 2026 results → · Compare in the interactive Sankey →